Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
Chemosphere|August 17, 2023
Synergistic effect of β-sitosterol and biochar application for improving plant growth of Thymus vulgaris under heat stressKhadiga Alharbi, Amir Abdullah Khan, Haifa Abdulaziz Sakit Alhaithloul, et al.
Oncotarget|March 24, 2016
A phase I study of indoximod in patients with advanced malignanciesHatem H Soliman, Susan E Minton, Hyo Sook Han, et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|December 4, 2014
Gene mutations in Wilson disease in Egyptian children: report on two novel mutationsFatma A El-Mougy, Sahar A A Sharaf, Marwa M Elsharkawy, et al.
BMC Cancer|March 5, 2021
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastasesMatthew N Mills, Chelsea Walker, Chetna Thawani, et al.
Journal of Neuro-Oncology|March 20, 2021
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastasesMatthew N Mills, Chetna Thawani, Nicholas B Figura, et al.
Cancer Medicine|September 30, 2021
Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropeniaJames Sun, Xiaojun Zhong, Junjie Ma, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2024
Multidisciplinary Management of Phyllodes Tumours and Breast Sarcoma: A Cross-sectional Survey of Clinical Practice across the UK and IrelandM K Bishr, J Banks, M S Abdelaziz, et al.
British Journal of Cancer|May 5, 2011
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approachesJ Lehmann-Che, F Amira-Bouhidel, E Turpin, et al.
BMC Cancer|May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastasesMatthew N Mills, Afrin Naz, Chetna Thawani, et al.
Scientific Reports|June 13, 2026
Anchusa azurea enhances cisplatin efficacy in oral and bone cancers through IL-17 and TNF-α pathway modulation: a metabolomic and network pharmacology approachSally A Fahim, Alaadin E El-Haddad, Rehab I Moustafa, et al.
Pageof 30